Healthcare

Size, Share, Trends, Growth, Opportunities, and Strategies in the STD Diagnostics Market 2024

The STD Diagnostics Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The STD Diagnostics Market:

https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report

According to The Business Research Company’s STD Diagnostics Global Market Report 2024, The std diagnostics market size has grown rapidly in recent years. It will grow from $9.25 billion in 2023 to $10.19 billion in 2024 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to epidemiological trends, healthcare infrastructure development, pharmaceutical developments, sexual education programs, demographic shifts..

The std diagnostics market size is expected to see strong growth in the next few years. It will grow to $14.82 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to personalized medicine trends, healthcare access improvements, population health strategies, telemedicine and digital health, rising incidence of stds.. Major trends in the forecast period include point-of-care testing (poct) advancements, home testing kits,multiplex testing, targeted marketing and outreach, pre-exposure prophylaxis (prep) programs, rising incidence rates..

The growing prevalence of STDs is driving the STD diagnostics market forward. STDs (sexually transmitted diseases) are infectious diseases that are transmitted from an infected person to a normal person through sexual contact. The STD diagnostics provide an efficient analysis and testing of this infection. For instance, in 2022, according to the World Health Organization (WHO), an international agency of the United Nations focusing on improving international public health, more than 1 million sexually transmitted infections are acquired every day globally. In addition, there are about 374 million new infections each year, with 1 of 4 STDs, chlamydia, gonorrhea, syphilis, and trichomoniasis. As a result, the rising prevalence of STDs propels the STD diagnostics market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=8507&type=smp

The std diagnostics market covered in this report is segmented –

1) By Type: Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing, Other Types

2) By Location Of Testing: Laboratory Testing, Point Of Care (PoC) Testing

3) By End-User: Hospitals And Clinics, Diagnostic Centers, Homecare

The advancement in STD diagnostics is a key trend in STD diagnostic market. Major players are upgrading the testing facilities and techniques to provide a better and fast diagnosis of sexually transmitted diseases. For instance, in May 2022, BD (Becton, Dickinson, and Company), a US-based medical technology company launched a fully automated, high-throughput infectious disease molecular diagnostics platform, known as BD CORTM MX/PX System. This platform unifies and automates the molecular laboratory workflow, from sample processing to diagnostic test results. The first test made accessible on the new platform is the BD CTGCTV2 molecular assay, which is a single test that can identify the three most common non-viral STIs (sexually transmitted infections): Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV).

The std diagnostics market report table of contents includes: